Eos Energy stock falls after Fuzzy Panda issues short report
Investing.com - Repligen (NASDAQ: RGEN) reported third quarter EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $189M versus the consensus estimate of $181.78M.
Guidance
Repligen sees FY 2025 EPS of $1.65-$1.68 versus the analyst consensus of $1.69.
Repligen sees FY 2025 revenue of $729.00M-$737.00M versus the analyst consensus of $727.80M.
Repligen’s stock price closed at $161.10. It is up 37.61% in the last 3 months and up 19.45% in the last 12 months.
Repligen saw 10 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Repligen’s stock price’s past reactions to earnings here.
According to InvestingPro, Repligen’s Financial Health score is "good performance".
Check out Repligen’s recent earnings performance, and Repligen’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
